Bharat Biotech has signed up with a CSIR lab to develop a synthetic process route for adjuvant molecule TLR 7/8 to Covaxin, using locally available chemicals. As export restrictions aren#39;t making life easy, many firms are entering into domestic tie-ups like this.COVID-19: Raw material crunch pushes vaccine makers to look at indigenization
Bharat Biotech has signed up with a CSIR lab to develop a synthetic process route for adjuvant molecule TLR 7/8 to Covaxin, using locally available chemicals. As export restrictions aren#39;t making life easy, many firms are entering into domestic tie-ups like this.
Subscribe to:
Post Comments (Atom)
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
No comments:
Post a Comment